首页> 外国专利> MTBK_20640 Vaccine composition for tuberculosis containing MTBK_20640 protein

MTBK_20640 Vaccine composition for tuberculosis containing MTBK_20640 protein

机译:MTBK_20640含MTBK_20640蛋白的结核病疫苗组合物

摘要

The present invention relates to tuberculosis treatment or prevention a pharmaceutical composition comprising a vaccine composition and MTBK_20640 protein for tuberculosis prevention, including MTBK_20640 protein. MTBK_20640 protein according to the invention exhibit a high IFN-γ producing ability in the spleen and lung in animal models induced by infection by M. tuberculosis and kept the memory screen in the Quick acquired protective immunity form and T cells by giving an effective prevention of tuberculosis is. In particular, it leads to the production of the recent multi-functional T cells, known to be important in the prevention of tuberculosis. Also available, even in the treatment of Tuberculosis recurrence or re-infection of the high recurrence rate, and highly pathogenic tuberculosis to be useful in improving the treatment efficiency. ;
机译:本发明涉及治疗或预防结核病的药物组合物,所述药物组合物包含疫苗组合物和用于预防结核病的MTBK_20640蛋白,包括MTBK_20640蛋白。在由结核分枝杆菌感染引起的动物模型中,根据本发明的MTBK_20640蛋白在脾脏和肺中表现出高的IFN-γ产生能力,并且通过有效地预防结核分枝杆菌而将记忆筛选保持在快速获得的保护性免疫形式和T细胞中。结核病是。特别是,它导致了最近的多功能T细胞的产生,这种多功能T细胞在预防结核病中很重要。也可用,即使在治疗结核病的复发或再次感染中也具有较高的复发率,而高致病性的结核病对于提高治疗效率是有用的。 ;

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号